A‐to‐I RNA Edited miR‐605‐3p Has a Heightened Anti‐Tumor Effect in Colorectal Cancer Through Modulating Immune Infiltration Mediated by CDK6
The Journal of Gene Medicine · 2025
DOI: 10.1002/jgm.70060 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2025. Verfasst von Xi-Zhong Cai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Xianyang Central Hospital, Xianyang, Shaanxi, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, MicroRNAs, Cyclin-Dependent Kinase 6, RNA Editing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Background
Adenosine‐to‐inosine (A‐to‐I) RNA editing represents a prevalent post‐transcriptional modification with profound implications for human diseases, particularly cancer. In colorectal cancer (CRC), the specific roles of A‐to‐I editing events remain inadequately understood. This study sought to elucidate the role and underlying mechanism of edited miR‐605‐3p in CRC.
Methods
The expression levels of miRNA and gene were assessed using RT‐qPCR, Western blotting, and immunohistochemistry. Tumor cell metastasis and proliferation were evaluated through Transwell and CCK‐8 assays, while flow cytometry was utilized to examine tumor cell apoptosis and CD8+ T cell populations. The relationship between gene and miRNA was confirmed via a dual‐luciferase reporter assay.
Results
In CRC tissues, the A‐to‐I RNA editing level of miR‐605‐3p was found to be elevated, which correlated with favorable clinical outcomes and prognosis in CRC patients. The ADAR2 enzyme is responsible for the overediting of miR‐605‐3p in CRC. Functionally, the wt‐miR‐605‐3p inhibited cell viability and metastasis of CRC, and its anti‐tumor efficacy of miR‐605‐3p was enhanced by A‐to‐I RNA editing. Mechanically, the edited‐miR‐605‐3p directly targets CDK6, in contrast to the wt‐miR‐605‐3p. Overexpression of CDK6 was observed to promote CRC cell proliferation and metastasis by impeding CD8+ T cell immune infiltration. MiR‐605‐3p overediting inhibited CRC tumor growth in vivo by downregulating CDK6.
Conclusion
The A‐to‐I RNA edited miR‐605‐3p demonstrates a more potent anti‐tumor effect in CRC by modulating CD8+ T cell immune infiltration mediated by CDK6. This study unveils edited miR‐605‐3p as a potential prognostic biomarker and highlights the ADAR2‐miR‐605‐3p axis as a novel therapeutic target for CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Xianyang Central Hospital, Xianyang, Shaanxi, China.
- Department of Oncology 1, Xianyang Central Hospital, Xianyang, Shaanxi, China.
ORCID-Profile: Chu-Yang Guo
Zitieren
APA
Cai, X. Z., Li, D. Y., Gou, K., Wang, S., & Guo, C. Y. (2025). A‐to‐I RNA Edited miR‐605‐3p Has a Heightened Anti‐Tumor Effect in Colorectal Cancer Through Modulating Immune Infiltration Mediated by CDK6. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.70060
Vancouver
Cai XZ, Li DY, Gou K, Wang S, Guo CY. A‐to‐I RNA Edited miR‐605‐3p Has a Heightened Anti‐Tumor Effect in Colorectal Cancer Through Modulating Immune Infiltration Mediated by CDK6. The Journal of Gene Medicine. 2025. doi:10.1002/jgm.70060
BibTeX
@article{Cai2025,
author = {Cai, Xi-Zhong and Li, Dan-Yang and Gou, Kuang and Wang, Shuai and Guo, Chu-Yang},
title = {A‐to‐I RNA Edited miR‐605‐3p Has a Heightened Anti‐Tumor Effect in Colorectal Cancer Through Modulating Immune Infiltration Mediated by CDK6},
journal = {The Journal of Gene Medicine},
year = {2025},
doi = {10.1002/jgm.70060}
}
EUVIMED